
Drug Target Models
GPCR Reporter Cells
Immunotherapy cells
Other Stable Cells
Assay Kits & Reagents
Services
Resources
Company
Cat. No: RQP74290
Size: 1 vial of frozen cells (>1E6 per vial in 1 mL)
Unit Price: Contact For Pricing
| Cat. No | RQP74290 |
| Product Name | CHO-K1 Human OX40L Cell |
| Product Type | Expression Cell line |
| Culture Properties | Adherent |
| Stability | 32passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Mycoplasma Status | Negative |
| Culture Medium | F12K+10%FBS+600 μg/ml Hygromycin B |
| Freeze Medium | 90% FBS+10% DMSO |
| Storage Conditions | Liquid nitrogen immediately upon delivery |
| Application | Binding Assay,FACS |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
CHO cell line expressing full length human OX40L. Expression is confirmed by flow cytometry.

Figure 1. Recombinant OX40L CHO stably expressing OX40L.
| Classification | Co-Stimulatory |
| Family | Tumor necrosis factor receptor superfamily |
| Gene Name | TNFRSF4 |
| Gene Aliases | ACT35;OX40;CD134 |
| Gene ID | 7293 |
| Accession Number | NM_003327.4 |
| UniProt Number | P43489 |
| Protein Name | Tumor necrosis factor receptor superfamily member 4 |
| Protein Aliases | ACT35 antigen;OX40L receptor;TAX transcriptionally-activated glycoprotein 1 receptor |
| Target Species | Human |
| Host cell | CHO-K1 |

Figure 2. Blocking of OX40L induced OX40 NFκB-Luc Jurkat(C29) Activity by OX40L Blocking Ab with OX40L CHO.
We Are Pleased to Announce: Global Commercial Licensing Rights for Jurkat E6.1, CHO-K1, and HEK293 Cell Lines Officially Secured.
Explore